Detalhe da pesquisa
1.
GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer.
Int J Mol Sci
; 24(13)2023 Jun 29.
Artigo
Inglês
| MEDLINE | ID: mdl-37446056
2.
Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphoma.
Blood
; 134(4): 363-373, 2019 07 25.
Artigo
Inglês
| MEDLINE | ID: mdl-31101621
3.
Targeting both BET and CBP/EP300 proteins with the novel dual inhibitors NEO2734 and NEO1132 leads to anti-tumor activity in multiple myeloma.
Eur J Haematol
; 106(1): 90-99, 2021 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-32997383
4.
Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non-Small Cell Lung Cancer.
Oncologist
; 24(6): 820-828, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30867242
5.
Molecular Biomarkers of Primary and Acquired Resistance to T-Cell-Mediated Immunotherapy in Cancer: Landscape, Clinical Implications, and Future Directions.
Oncologist
; 23(4): 410-421, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29242279
6.
Merestinib blocks Mnk kinase activity in acute myeloid leukemia progenitors and exhibits antileukemic effects in vitro and in vivo.
Blood
; 128(3): 410-4, 2016 07 21.
Artigo
Inglês
| MEDLINE | ID: mdl-27307295
7.
Role of artificial intelligence in the care of patients with nonsmall cell lung cancer.
Eur J Clin Invest
; 48(4)2018 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-29405289
8.
9-ING-41, a small-molecule glycogen synthase kinase-3 inhibitor, is active in neuroblastoma.
Anticancer Drugs
; 29(8): 717-724, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-29846250
9.
A case of pembrolizumab-induced type-1 diabetes mellitus and discussion of immune checkpoint inhibitor-induced type 1 diabetes.
Cancer Immunol Immunother
; 66(1): 25-32, 2017 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27761609
10.
Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib.
Haematologica
; 102(8): 1361-1367, 2017 08.
Artigo
Inglês
| MEDLINE | ID: mdl-28522574
11.
Is Personalized Medicine Here?
Oncology (Williston Park)
; 30(4): 293-303, 307, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-27085327
12.
Human endogenous retrovirus K and cancer: Innocent bystander or tumorigenic accomplice?
Int J Cancer
; 137(6): 1249-57, 2015 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-24890612
13.
Pevonedistat (MLN4924), a First-in-Class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study.
Br J Haematol
; 169(4): 534-43, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25733005
14.
Targeting novel signaling pathways for resistant acute myeloid leukemia.
Mol Genet Metab
; 114(3): 397-402, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25533111
15.
Blinatumomab for the treatment of acute lymphoblastic leukemia.
Invest New Drugs
; 33(6): 1271-9, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26383529
16.
Synthetic high-density lipoprotein-like nanoparticles as cancer therapy.
Cancer Treat Res
; 166: 129-50, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25895867
17.
New strategies for relapsed acute myeloid leukemia: fertile ground for translational research.
Curr Opin Hematol
; 21(2): 79-86, 2014 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-24419335
18.
Elevated HERV-K mRNA expression in PBMC is associated with a prostate cancer diagnosis particularly in older men and smokers.
Carcinogenesis
; 35(9): 2074-83, 2014 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-24858205
19.
Inhibition of protein synthesis and JNK activation are not required for cell death induced by anisomycin and anisomycin analogues.
Biochem Biophys Res Commun
; 443(2): 761-7, 2014 Jan 10.
Artigo
Inglês
| MEDLINE | ID: mdl-24333448
20.
The role of inflammation in leukaemia.
Adv Exp Med Biol
; 816: 335-60, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24818729